Диссертация (1154740), страница 20
Текст из файла (страница 20)
323-6.85.Autologouscellseededbiodegradablescaffoldfor augmentationcystoplasty: phase II study in children and adolescents with spina bifida / Joseph D.B.,Borer J.G., De Filippo R.E., Hodges S.J. [et al.] // J. Urol. — 2014. — N. 191(5). —P. 1389-95.86.Biers, S.M.
The past, present and future of augmentation cystoplasty /Biers S.M., Venn S.N., Greenwell T.J. // BJU Int. — 2012. — N. 109(9). — P. 1280-93.12187.Biomatrices for bladder reconstruction / Lin H.K., Madihally S.V.,Palmer B., Frimberger D. [et al.] // Adv. Drug Deliv. Rev. — 2015. — N. 82-83. —P. 47-63.88.Bladder acellular matrix conjugated with basic fibroblast growth factor forbladder regeneration / Chen W., Shi C., Hou X., Zhang W. [et al.] // Eng. Part. A. —2014. — N. 20(15-16). — P. 2234-42.89.Bladder Acellular Matrix Grafts Seeded with Adipose-Derived Stem Cellsand Incubated Intraperitoneally Promote the Regeneration of Bladder Smooth Muscleand Nerve in a Rat Model of Bladder Augmentation / Zhe Z., Jun D., Yang Z.,Mingxi X.
[et al] // Stem Cells Dev. — 2016. — Vol.1. — N. 25(5). — P. 405-14.90.Bladder augmentation in rabbits with anionic collagen membrane, with orwithout urotelial preservation. Cistometric and hystologic evaluation / Lepper F.,Ramos T., Trindade Filho J., Vale F. [et al.] // International Braz. J. Urol. — 2002. —Vol. 28 (5). — P. 464-470.91.Bladder augmentation using acellular collagen biomatrix: a pilotexperience in exstrophic patients / Pediatr Caione P., Boldrini R., Salerno A.,Nappo S.G. // Surg. Int. — 2012. — N. 28(4).
— P. 421-8.92.Bladder augmentation using tissue-engineered autologous oral mucosalepithelial cell sheets grafted on demucosalized gastric flaps / Watanabe E., Yamato M.,Shiroyanagi Y., Tanabe K. [et al.] // Transplantation. — 2011. — Vol. 15. —N. 91(7). — P. 700-6.93.Bladder calculi in the augmented bladder: a follow-up study of 160children and adolescents / Kisku S., Sen S., Karl S., Mathai J. [et al.] // J. Pediatr.Urol. — 2015.
— N. 11(2). — P. 66.94.Bladder muscular wall regeneration with autologous adipose mesenchymalstem cells on three-dimensional collagen-based tissue-engineered prepuce andbiocompatible nanofibrillar scaffold / Kajbafzadeh A.M., Tourchi A., Mousavian A.A.,Rouhi L. [et al.] // J. Pediatr. Urol. — 2014. — N. 10(6). — P. 1051-8.95.Bladder reconstruction using scaffold-less autologous smooth muscle cellsheet engineering: early histological outcomes for autoaugmentation cystoplasty /122Talab S.S., Kajbafzadeh A.M., Elmi A., Tourchi A. [et al.] // BJU Int. — 2014.
—N. 114(6). — P. 937-45.96.Bladder regeneration using a smart acellular collagen scaffold with growthfactors VEGF, FGF2 and HB-EGF / Roelofs L.A., Oosterwijk E., Kortmann B.B.,Daamen W.F. [et al.] // Tissue Eng. Part. A. — 2016. — N. 22(1-2). — P. 83-92.97.Bladder smooth muscle cells differentiation from dental pulp stem cells:future potential for bladder tissue engineering. stem / Song B., Jiang W., Alraies A.,Liu Q.
[et al.] // Cells Int. — 2016. — doi: 10.1155/2016/6979368.98.Bladder tissue engineering: a literature review / Lam Van Ba O.,Aharony S., Loutochin O., Corcos J. // Adv. Drug Deliv. Rev. — 2015. — N. 82-83. —P. 31-7.99.Bladder tissue engineering: tissue regeneration and neovascularizationofHA-VEGF-incorporated bladder acellular constructs in mouse and porcine animalmodels / Loai Y., Yeger H., Coz C., Antoon R. [et al.] // J.
Biomed. Mater. Res. A. —2010. — Vol. 15. — N. 94(4). — P. 1205-15.100. Bone marrow derived cells facilitate urinary bladder regeneration byattenuating tissue inflammatory responses / Bury M.I., Fuller N.J., Wethekam L.,Sharma A.K. // Cent. European J. Urol. — 2015. — N. 68(1). — P. 115-20.101. Bouhout, S. A Novel and Faster Method to Obtain a Differentiated 3Dimensional Tissue Engineered Bladder // Bouhout S., Goulet F., Bolduc S. // J.Urol.
— 2015. — N. 194(3). — P. 834-41.102. Bouhout, S. Maintenance of bladder urothelia integrity and successfulurothelialization of various tissue-engineered mesenchymes in vitro / Bouhout S.,Tremblay J., Bolduc S. // In Vitro Cell Dev. Biol. Anim. — 2015. — N. 51(9). —P. 922-31.103. Buccal mucosa ureteroplasty for the treatment of complex ureteric injury /Sadhu S., Pandit K., Roy M.K., Bajoria S.K. // Indian J.
Surg. — 2011. — N. 73(1). —P. 71-2.123104. Cavernous hemangioma of the bladder: an additional case managed bypartial cystectomy and augmentation cystoplasty / Lahyani M., Slaoui A., Jakhlal N.,Karmouni T. [et al.] // Pan. Afr. Med. J. — 2015. — Vol. 13. — N. 22. — P. 131.105. Cell Therapy for Stress Urinary Incontinence / Hart M.L., Izeta A.,Herrera-Imbroda B., Amend B. [et al.] // Tissue Eng. Part. B. Rev. — 2015.
—N. 21(4). — P. 365-76.106. Cell-seeded tubularized scaffolds for reconstruction of long urethraldefects: a preclinical study / Orabi H., AbouShwareb T., Zhang Y., Yoo J.J. [et al.] //Eur. Urol. — 2013. — N. 63(3). — P. 531-8.107. Characterization of urine-derived stem cells obtained from upper urinarytractfor use in cell-based urological tissue engineering / Bharadwaj S., Liu G., Shi Y.,Markert C. [et al.] // Tissue Eng.
Part. A. — 2011. — N. 17(15-16). — P. 2123-32.108. Cheng, H.L. Monitoring tissue development in acellular matrix-basedregeneration for bladder tissue engineering: multiexponential diffusion and T2* forimproved specificity / Cheng H.L., Loai Y., Farhat W.A. // NMR Biomed. — 2012. —N.
25(3). — P. 418-26.109. Chung, E. Stem-cell-based therapy in the field of urology: a review of stemcell basic science, clinical applications and future directions in the treatment of varioussexual and urinary conditions / E. Chung // Expert Opin. Biol. Ther. — 2015. —N. 15(11). — P. 1623-32.110. Coadministration of platelet-derived growth factor-BB and vascularendothelial growth factor with bladder acellular matrix enhances smooth muscleregeneration and vascularization for bladder augmentation in a rabbit model / Zhou L.,Yang B., Sun C., Qiu X.
[et al.] // Tissue Eng. Part. A. — 2013. — N. 19(1-2). —P. 264-76.111. Co-delivery of VEGF and bFGF via a PLGA nanoparticle-modified BAMfor effective contracture inhibition of regenerated bladder tissue in rabbits / Jiang X.,Lin H., Jiang D., Xu G. [et al.] // Sci. Rep. — 2016. — N. 8;6. — P. 20784.112. Combined injection of three different lineages of early-differentiatinghuman amniotic fluid-derived cells restores urethral sphincter function in urinary124incontinence / Chun S.Y., Kwon J.B., Chae S.Y., Lee J.K. [et al.] // BJU Int.
—2014. — N. 114(5). — P. 770-83.113. Comparative Outcomes and Perioperative Complications of Robotic Vs.Open Cystoplasty and Complex Reconstructions / Cohen A.J., Brodie K., Murthy P.,Wilcox D.T., Gundeti M.S. // Urology. — 2016. — N. 18.114. Comparing supportive properties of poly lactic-co-glycolic acid (PLGA),PLGA/collagen and human amniotic membrane for human urothelial and smoothmuscle cells engineering / Sharifiaghdas F., Naji M., Sarhangnejad R., RajabiZeleti S. // Urol. J. — 2014.
— Vol. 8. —N. 11(3). — P. 1620-8.115. Complications after bladder augmentation in children / Molina C.A.,Lima G.J., Cassini M.F., Andrade M.F. [et al.] // Acta Cir. Bras. — 2016. — N. 31. —Suppl. 1. — P. 8-12.116. Complications after use of gastric segments for lower urinary tractreconstruction / Castellan M., Gosalbez R., Bar-Yosef Y., Labbie A. // Urol.
—2012. — N. 187(5). — P. 1823-7.117. Constructs of electrospun PLGA, compressed collagen and mincedurothelium for minimally manipulated autologous bladder tissue expansion /Ajalloueian F., Zeiai S., Fossum M., Hilborn J.G. // Biomaterials. — 2014. —N. 35(22). — P. 5741-8.118. Cystectasy and rehabilitation training for treatment of neurogenic bladderdysfunction with hyperreflexia / Li L., Fan Y., Li H., Zhang Q.
[et al.] // Zhongguo XiuFu Chong Jian Wai Ke Za Zhi. — 2016. — N. 30(2). — P. 224-8.119. Different bladder defects reconstructed with bladder acellular matrix graftsin a rabbit model / Zhu W.D., Xu Y.M., Feng C. [et al.] // Urologe A. — 2011. —N. 50(11). — P. 1420-5.120. Do mesenchymal stem cells modulate the milieu of reconstructed bladderwall? / Pokrywczynska M., Jundzill A., Bodnar M., Adamowicz J.
[et al.] // Arch.Immunol. Ther. Exp. (Warsz). — 2013. — N. 61(6). — P. 483-93.125121. Dugi, D.D. 3rd. Urethroplasty for Stricture Disease: ContemporaryTechniques and Outcomes / Dugi D.D. 3rd, Simhan J., Morey A.F. // Urology. —2016. — N. 89. — P.
12-8.122. Engineered insulin-like growth factor-1 for improved smooth muscleregeneration / Lorentz K.M., Yang L., Frey P., Hubbell J.A. // Biomaterials. — 2012. —N. 33(2). — P. 494-503.123. Evaluation of biomaterials for bladder augmentation using cystometricanalyses in various rodent models / Tu D.D., Seth A., Gil E.S., Kaplan D.L. [et al.] // J.Vis. Exp. — 2012.
— N. 9. — P. 66.124. Evaluation of electrospun bioresorbable scaffolds for tissue-engineeredurinary bladder augmentation / Del Gaudio C., Vianello A., Bellezza G., Maulà V.[et al.] // Biomed Mater. — 2013. — N. 8(4):045013.125. Evaluation of viability and proliferative activity of human urothelial cellscultured onto xenogenic tissue-engineered extracellular matrices / Davis N.F.,Callanan A., McGuire B.B., Flood H.D.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
